₹ 19.85
-2.14 (-9.73%)
BSE
V
Vanta Bioscience
₹ 19.85
BSE
VANTABIO Financials Summary (Consolidated)
Vanta Bioscience revenue decreased 53.57% quarter-on-quarter to ₹1 Cr in Mar 2023, while net loss narrowed to ₹1 Cr from ₹3 Cr in the previous quarter. EPS for the quarter stood at ₹0.00, increased from -₹4.06 in the previous quarter.
Vanta Bioscience Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of VANTABIO Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
VANTABIO Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






